World-renowned oncologist Dr. Baofa Yu MD has opened 3 hospitals within 3 different cities in China, including Beijing, that specialize in treating solid tumors. He has developed a new intra-tumor treatment called UMIPIC - Ultra Minimum Incision Personalized Intra-Tumoral ChemoImmunology Therapy, which has been used to treat over 50000 patients in 21 years, with superior advantages and results as compared to other treatment therapies.
Dr. Yu attended the San Diego Medical School of UCSD to continue his postdoctoral study in 1990 after graduating from Chinese medical college and gaining four years of working experience in hospitals in China. He performed drug delivery research for cancer therapy in the Cancer Center of UCSD for two years. Following that, he conducted research involving the molecular biology of cancer in the Salk Institute for Biological Studies for two years; then he worked in a clinical department for four years, specializing in oncology and as an assistant professor of UCSD. He has now published more than 15 papers in a variety of scientific journals.
American SALK medical research group photo
The patent certificate
Group photo of all staff